After allegations of insider trading, Divi's Laboratories chief financial officer (CFO) L Kishore Babu has gone on leave for three months.
"L Kishore Babu, Chief Financial Officer of the company is proceeding on leave for a period of 3 months effective from 18 July, 2020, to resolve the allegations of lnsider Trading against him in SEBI's Impounding Order cum Show cause notice," Divi's Laboratories said in a statement to stock exchanges.
Venkatesa Perumallu Pasumarthy will temporarily handle the non-statutory duties of the CFO, the company added.
Market regulator Securities and Exchange Board of India (SEBI) had on July 1 issued a notice alleging insider trading activities in Divi's Laboratories' scrip between July 7 and 10, 2017.SEBI's order stated that Babu and seven others had made gains of around Rs 96.68 lakh in July 2017 from trading in Divi's Laboratories share after accessing information on US Food and Drugs Administration clearance, BloombergQuint reported.
After the FDA clearance of Divi's pharma manufacturing unit in Visakhapatnam was announced on July 10, the share price jumped 7 percent and volumes surged 3,200 percent, the report added.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!